SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-011443
Filing Date
2023-03-31
Accepted
2023-03-31 17:27:06
Documents
19
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-20230329.htm   iXBRL 8-K 77373
2 EX-1.1 UNDERWRITING AGREEMENT vktx-ex1_1.htm EX-1 350070
3 EX-5.1 LEGAL OPINION vktx-ex5_1.htm EX-5 15792
4 EX-99.1 PRESS RELEASE vktx-ex99_1.htm EX-99 23180
5 GRAPHIC img201808844_0.jpg GRAPHIC 13142
6 GRAPHIC img246856755_0.jpg GRAPHIC 5454
7 GRAPHIC img246856755_1.jpg GRAPHIC 18957
8 GRAPHIC img246856755_2.jpg GRAPHIC 5454
  Complete submission text file 0000950170-23-011443.txt   715927

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vktx-20230329.xsd EX-101.SCH 2492
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vktx-20230329_lab.xml EX-101.LAB 17757
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vktx-20230329_pre.xml EX-101.PRE 11130
13 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20230329_htm.xml XML 4719
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 23789337
SIC: 2834 Pharmaceutical Preparations